glp 1 thyroid Increased GLP-1 Cancer Risks May Be Product of More Intense Screening, Study Finds Glucagon-like peptide-1 receptor (GLP-1R) expression
Description
A new survey report from the International Foundation of Employee Benefit Plans reveals results from a group of Canadian employers regarding considerations and coverage for glucagon-like peptide-1 (GLP-1) drugs, which have historically been used to treat diabetes and are increasingly being used to treat obesity
Access pathways have diversified
Retatrutide changes the equation entirely
In addition, more phase II and phase III studies are underway to further assess the role of these agents in managing the disease
